CLINICAL_TRIALS
trial_result
· 2021-11-01
Clinical Trial Update: Effect of Vandetanib on Cellular Markers in Invasive Breast Cancer [Phase 2]
Summary
Phase 2 trial investigating vandetanib's effect on cellular markers in invasive breast cancer; study terminated with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ronald Weigel | Conditions: Invasive Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2021-11-01